O’Shaughnessy review: Protas, Oxford and Good Clinical Trials Collaborative respond
Together, the three organisations are calling for actions not words in The Lancet.
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Together, the three organisations are calling for actions not words in The Lancet.
Protas is delighted to welcome Esther Krofah MPP to its Board of Directors.
The Economist interviewed Prof Sir Martin Landray about what can be done to solve the clinical trials crisis.
Protas was highlighted in the report as an organisation that is focused on showing how clinical trials can be done differently.
This Clinical Trials Day, hear from some of the people behind our work at Protas.
This Clinical Trials Day, hear from some of the people behind our work at Protas.
This Clinical Trials Day, hear from some of the people behind our work at Protas.
Protas announces the appointment of Professor Richard Haynes MBE DM FRCP to its Executive Team.
The UKAS accredited certification is the international standard for information security management systems.
Hear from some of the women behind our work at Protas in this IWD series.
Hear from some of the women behind our work at Protas in this IWD series.
Hear from some of the women behind our work at Protas in this IWD series.